1.Spearman, C.W.; Dusheiko, G.M.; Hellard, M.; Sonderup, M. Hepatitis C.Lancet2019,394, 1451–1466. [Google Scholar] [CrossRef]2.World Health Organization—WHO.Global Hepatitis Report 2017; World Health Organization: Geneva, Switzerland, 2017. [Google Scholar]3.World Health Organization Hepatitis C. Available online:https://www.who.int/news-room/fact-sheets/detail/hepatitis-c(accessed on 29 February 2020).4.Gottwein, J.M.; Bukh, J. Cutting the Gordian Knot-Development and Biological Relevance of Hepatitis C Virus Cell Culture Systems.Adv. Virus Res.2008,71, 51–133. [Google Scholar] [CrossRef] [PubMed]5.Borgia, S.M.; Hedskog, C.; Parhy, B.; Hyland, R.H.; Stamm, L.M.; Brainard, D.M.; Subramanian, M.G.; McHutchison, J.G.; Mo, H.; Svarovskaia, E.; et al. Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes.J. Infect. Dis.2018,218, 1722–1729. [Google Scholar] [CrossRef] [PubMed] [Green Version]6.Thomas, E.; Feld, J.J.; Li, Q.; Hu, Z.; Fried, M.W.; Liang, T.J. Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models.Hepatology2011,53, 32–41. [Google Scholar] [CrossRef] [PubMed]7.Spengler, U. Direct antiviral agents (DAAs)—A new age in the treatment of hepatitis C virus infection.Pharmacol. Ther.2018,183, 118–126. [Google Scholar] [CrossRef]8.Levrero, M. Viral hepatitis and liver cancer: The case of hepatitis C.Oncogene2006,25, 3834–3847. [Google Scholar] [CrossRef] [Green Version]9.Medzhitov, R.; Janeway, C.A. Innate Immunity: The Virtues of a Nonclonal System of Recognition.Cell1997,91, 295–298. [Google Scholar] [CrossRef] [Green Version]10.Janeway, C.A.; Medzhitov, R. Innate Immune Recognition.Annu. Rev. Immunol.2002,20, 197–216. [Google Scholar] [CrossRef] [Green Version]11.Gao, B.; Jeong, W.-I.; Tian, Z. Liver: An organ with predominant innate immunity.Hepatology2008,47, 729–736. [Google Scholar] [CrossRef]12.Thompson, M.R.; Kaminski, J.J.; Kurt-Jones, E.A.; Fitzgerald, K.A. Pattern recognition receptors and the innate immune response to viral infection.Viruses2011,3, 920–940. [Google Scholar] [CrossRef] [Green Version]13.Moradpour, D.; Penin, F.; Rice, C.M. Replication of hepatitis C virus.Nat. Rev. Microbiol.2007,5, 453–463. [Google Scholar] [CrossRef] [PubMed]14.Ito, M.; Masumi, A.; Mochida, K.; Kukihara, H.; Moriishi, K.; Matsuura, Y.; Yamaguchi, K.; Mizuochi, T. Peripheral B Cells May Serve as a Reservoir for Persistent Hepatitis C Virus Infection.J. Innate Immun.2010,2, 607–617. [Google Scholar] [CrossRef] [PubMed]15.Egger, D.; Wölk, B.; Gosert, R.; Bianchi, L.; Blum, H.E.; Moradpour, D.; Bienz, K.; Bianchi, L. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex.J. Virol.2002,76, 5974–5984. [Google Scholar] [CrossRef] [PubMed] [Green Version]16.Gosert, R.; Egger, D.; Lohmann, V.; Bartenschlager, R.; Blum, H.E.; Bienz, K.; Moradpour, D. Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells HarboringSubgenomic Replicons.J. Virol.2003,77, 5487–5492. [Google Scholar] [CrossRef] [Green Version]17.Bartenschlager, R.; Lohmann, V. Replication of hepatitis C virus.J. Gen. Virol.2000,81, 1631–1648. [Google Scholar] [CrossRef]18.Enomoto, N.; Sato, C. Hepatitis C virusquasispeciespopulations during chronic hepatitis C infection.Trends Microbiol.1995,3, 445–447. [Google Scholar] [CrossRef]19.Tsukiyama-Kohara, K.; Kohara, M. Hepatitis C Virus: ViralQuasispeciesand Genotypes.Int. J. Mol. Sci.2018,19, 23. [Google Scholar] [CrossRef] [Green Version]20.Bartenschlager, R.; Penin, F.; Lohmann, V.; André, P. Assembly of infectious hepatitis C virus particles.Trends Microbiol.2011,19, 95–103. [Google Scholar] [CrossRef]21.Boulant, S.; Douglas, M.W.; Moody, L.; Budkowska, A.; Targett-Adams, P.; McLauchlan, J. Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule-and dynein-dependent manner.Traffic2008,9, 1268–1282. [Google Scholar] [CrossRef]22.Suzuki, T. Assembly of hepatitis C virus particles.Microbiol. Immunol.2011,55, 12–18. [Google Scholar] [CrossRef]23.Tews, B.A.; Popescu, C.-I.; Dubuisson, J. Last stop before exit—Hepatitis C assembly and releaseas antiviral drug targets.Viruses2010,2, 1782–1803. [Google Scholar] [CrossRef] [PubMed]